Reports
Prohibition Partners provides reliable and credible data on commercial opportunities, market sizes and the regulatory environment in key cannabis markets.
Download now
Latest Release
The European Cannabis Report 5th Edition
The landscape of the European cannabis industry is shifting as quickly as the legislation that underpins it. The European Cannabis Report: 5th Edition, revisits the landscape of cannabis in Europe, providing insights into the latest developments across the continent, and delivering intelligence across key markets such as France, Portugal, Germany, Italy, Spain and the UK. The report helps unpack complex legislation and key data for international policymakers and industry-leading operators.
The European Cannabis Report 5th Edition examines:
• Comprehensive analysis of European cannabis legislation
• Proprietary market forecasts for key cannabis markets
• An overview of commercial opportunities across multiple industry sectors
In collaboration with:
Prohibition Partners’ exclusive reports provide the most in-depth coverage of the international cannabis industry. Our analysts present reliable and credible data on commercial opportunities, market sizes and the regulatory environment in key cannabis markets. We specialise in explaining the latest legislative developments and key industry trends in the cannabis industry – our research has been cited by political leaders, Fortune 500 companies, entrepreneurs and investors.
Our analysts and local experts compile data from a range of sources including government bodies, market surveys, media agencies and private businesses.
Download our reports
The Impact Series: Disrupting Beauty
Prohibition Partners is proud to present Disrupting Beauty, the first report in our 'Impact Series’ showcasing how cannabis is permeating the mainstream. Disrupting Beauty documents how cannabis is disrupting the traditional beauty market and the supply chain as demand skyrockets for cannabis beauty products.
The Impact Series: Disrupting Beauty examines:
• The brands and businesses driving the cannabis beauty market
• Market forecasts for the cannabis beauty industry
• Key regulations and legislation dictating the sector
Download our reports
The UK Cannabis Report
The UK Cannabis Report delivers a comprehensive and complete analysis of the UK cannabis sector, providing expert commentary on the newly published NICE Guidelines and breakdowns of the latest developments across the sector. The report features the latest data from a market which is expected to be worth US$4.3 billion by 2024. Download the full report to access industry-leading research and expert opinions covering healthcare, commercial activity and investment trends in the UK market.
The UK Cannabis Report examines:
• Analysis of the recently published NICE guidelines
• Market forecasts contextualising the UK within the global cannabis market
• Commercial advice for industry experts, investors and influencers
In collaboration with:
Download our reports
The New Normal Report
Prohibition Partners is proud to present The New Normal Report, in collaboration with Protein Agency. The report documents the rise of CBD and the permeation of cannabis into the mainstream, exploring the brands and businesses that are driving growth across beauty, sport, lifestyle and food and drink sectors. The report takes a deep-dive into consumer trends and examines how brands can connect with the emerging cannabis consumer. Download for free now.
The New Normal Report examines:
• Data on the international CBD market
• Analysis of consumer behaviour and future trends
• Advice for brands looking to engage with cannabis consumers
Download our reports
The Global Cannabis Report
The landscape of the global cannabis industry is shifting as quickly as the legislation that underpins it. The Prohibition Partners' The Global Cannabis Report, an industry first of its kind, analyses the key developments across the global cannabis sector and provides proprietary market forecasts across the continental markets: Africa, Asia, Europe, Latin America, North America and Oceania. The report predicts that the international cannabis market could be worth up to US$103.9 billion by 2024, and outlines key commercial opportunities for international operators and investors.
The Global Cannabis Report examines:
• Comprehensive analysis of international cannabis legislation
• Proprietary market forecasts for key cannabis markets
• An overview of commercial opportunities across multiple industry sectors
In collaboration with:
Download our reports
The Poland Cannabis White Paper
Poland is expected to play a central role in the European cannabis market in the coming years, after becoming the 12th country to legalise medicinal cannabis on the continent in 2017. With the Polish market expected to be worth at least €2 billion by 2028, key opportunities will be available to investors, entrepreneurs and influencers in the near future.
The Poland Cannabis White Paper examines:
• Commercial and business opportunities in the region
• Changing legislation and new regulatory guidelines
• Emerging trends, market forecasts, consumption data and industry insights
Download our reports
The Germany Cannabis Report
The Germany Cannabis Report is the first and only free-to-access report to focus on the biggest economy in Europe and its burgeoning cannabis market. Having legalised medical cannabis in 2017 and achieved a market value of over €73 million in 2018, Germany is set to play a central role in the European market in the coming years, which is estimated to be worth over €123 billion by 2028.
The Germany Cannabis Report examines:
• Commercial and business opportunities
• Changing legislation and new regulatory guidelines
• Emerging trends, market forecasts, consumption data and industry insights
In collaboration with:
Download our reports
The North American Cannabis Report
The North American Cannabis Report is the first and only free-to-access report on the cannabis industry in the United States and Canada, a market worth a potential $47.3 billion by 2024. Although the US is currently the most profitable cannabis industry in the world, the lack of legislative clarity at the federal level is disrupting the industry. Canada has taken a leadership position at the international level, having legalised recreational cannabis in October 2018. The market is set to grow at an unprecedented rate over the next five years, as legislation shifts in favour of liberalisation and consumer industries begin to move in on the cannabis space.
The North American Cannabis Report examines:
• Commercial and business opportunities at both state and federal level
• Changing legislation and new regulatory guidelines across the region
• Emerging trends, market forecasts, consumption data and industry insights
In collaboration with:
Download our reports
The Cannabis Legal Report™
Prohibition Partners’ inaugural The Cannabis Legal Report™ provides the most comprehensive review of the legislation and regulation governing the emerging legal cannabis market. Attitudes towards medical cannabis are shifting amongst the public, and policymakers, professionals and investors are beginning to take note. This report runs through the crucial insights needed to understand the burgeoning cannabis market which could be worth an estimated €123 billion by 2028 in Europe alone.
The Cannabis Legal Report™ examines:
• The major legislative hurdles facing the global cannabis market
• The emerging regulatory models employed in legal jurisdictions
• Key legal markets across the globe
In collaboration with:
Download our reports
The European Cannabis Report™ 4th Edition
Home to more than 740 million people, a population more than double that of the United States and Canada combined, Europe is set to become the world’s largest legal cannabis market over the next five years. In the last 12 months alone, the European cannabis industry has grown more than in the last six years. Six countries have announced new legislation and over €500million has been invested in European cannabis businesses and as our exclusive research shows, Europe’s cannabis market is estimated to be worth up to €123 billion by 2028.
The European Cannabis Report™ 4th Edition examines:
• Commercial and business opportunities in 33 European markets
• Changing legislation and new regulatory guidelines across the region
• Emerging trends, market forecasts and industry insights
In collaboration with:
Download our reports
The Asian Cannabis Report™
Asia, the world’s most populous continent, has a relatively low prevalence of cannabis use at just 2% annually. However, this is the equivalent to an estimated 85.5 million people, making Asia a key market in the long-term expansion plans of producers, investors and operators. As the historically conservative stance on cannabis begins to soften, the medical market alone could be worth as much as US$5.8 billion by 2024.
The Asian Cannabis Report™ examines:
• Commercial and business opportunities in 7 key Asian markets
• Legislation and recent regulatory changes across the region
• Emerging trends, market forecasts and industry insights
In collaboration with:
Download our reports
The African Cannabis Report™
While cannabis remains illegal in most African countries, many nations are keen to embrace cultivation as a way to boost their economies. Cannabis is already widely grown and consumed across the continent with production currently standing at around 38,000 tonnes and consumption rates at 13.2%. While any path towards a legalised and regulated cannabis industry presents a number of significant challenges due to opaque laws and inconsistent enforcement, Africa’s climate, affordable land and low-cost labour offer enormous opportunities in a market that could exceed $US7.1 billion by 2023.
The African Cannabis Report™ examines:
• Commercial and business opportunities in 9 African markets
• Legislation and the latest regulatory guidelines across the region
• Emerging trends, market forecasts and industry insights
In collaboration with:
Download our reports
Medical Cannabis in Europe – The GMP Standards Guide
Prohibition Partners is excited to announce the launch of 'Medical Cannabis in Europe - The GMP Standards Guide', in association with Orion GMP Solutions. As European legislators start to develop and implement national cannabis programmes using EU Good Manufacturing Practice guidelines, we examine how these requirements impact the cultivation, importation and distribution of medical cannabis within the EU.
In collaboration with:
Download our reports
The Oceania Cannabis Report™
Australia legalised medical cannabis in October 2016. Two years later, they aim to become one of the global leaders in the legal cannabis industry establishing themselves as major players in the cultivation, manufacturing and distribution industries.
The Oceania Cannabis Report™ examines:
• Key opportunities and legislation in the Oceania region
• Market predictions for Australian and New Zealand cannabis markets
• Emerging companies and trends from the Oceania region
In collaboration with:
Download our reports
The LATAM Cannabis Report™
The LATAM market is expected to grow rapidly over the next 10 years. The region is quickly introducing some of the most relaxed legislation on legal cannabis in the world, in a bid to become a global leader in medical cannabis cultivation.
The LATAM Cannabis Report™ examines:
• Market size and industry data across the LATAM cannabis industry
• Commercial opportunities, regulatory environments and healthcare analyses in 10 key cannabis markets
• Emerging trends and insights into the nascent LatAm cannabis industry
In collaboration with:
Download our reports
The European Cannabis Report™
Regulatory changes, public support and evidence of cannabis’ therapeutic effects are driving growth in the European cannabis industry. The market itself has the potential to be worth €115 billion but the size of Europe’s opportunity is counterbalanced by the scale of complexity in navigating each country’s unique legal framework.
The European Cannabis Report™ examines:
• Investment growth across cannabis industry sectors
• Number of deals & total capital raised in the industry
• Emerging trends between equity and debt investments
In collaboration with:
